Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery — EACA

Aortic Disease Clinical Trial

Official title:
The Effect of Standard vs Aggressive Dosing Regimens for Epsilon-aminocaproic Acid on a Quantifiable Parameter of Fibrinolysis as Measured by Thromboelastography

Status Terminated

Clinical Trial Summary

This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01965730
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Terminated
Phase	Early Phase 1
Start date	January 2013
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05603520` - Phenotyping Heterogeneity and Regionality of the Aorta
Terminated	`NCT01033370` - A Safety and Efficacy Study of Blood Pressure Control in Acute Aortic Emergencies - A Pilot Study (PROMPT)	Phase 4
Completed	`NCT02136979` - Effect of Anesthetics on CD39 and CD73 After Open-heart Surgery	Phase 4
Completed	`NCT01081210` - Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound
Terminated	`NCT01805973` - Surviving Aneurysm Surgery: A Pilot Study on Exercise Training in Abdominal Aortic Aneurysm Patients	N/A
Recruiting	`NCT02524834` - Endovascular Repair of Descending ThoracoAbdominal Aortic Pathologies Using Physician Modified Endovascular Prosthesis	N/A
Completed	`NCT01234610` - Feasibility Study of Exercise Training for Abdominal Aortic Aneurysm Disease	N/A
Completed	`NCT01331187` - Influence of Routinely Adding Ultrasound Screening in Medical Department	N/A